IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 118 filers reported holding IMMUNOVANT INC in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $178,398 | +84.1% | 4,647 | -9.0% | 0.11% | +89.5% |
| Q2 2023 | $96,880 | -6.8% | 5,107 | -23.8% | 0.06% | 0.0% |
| Q1 2023 | $103,933 | -36.9% | 6,701 | -27.8% | 0.06% | -33.7% |
| Q4 2022 | $164,649 | -2.6% | 9,276 | -69.5% | 0.09% | +28.4% |
| Q3 2022 | $169,000 | +43.2% | 30,367 | +0.7% | 0.07% | +52.3% |
| Q2 2022 | $118,000 | +0.9% | 30,146 | +42.5% | 0.04% | -15.4% |
| Q1 2022 | $117,000 | -38.7% | 21,162 | -5.7% | 0.05% | -27.8% |
| Q4 2021 | $191,000 | +11.0% | 22,435 | +13.3% | 0.07% | -5.3% |
| Q3 2021 | $172,000 | -21.8% | 19,794 | -5.0% | 0.08% | -15.6% |
| Q2 2021 | $220,000 | +122.2% | 20,827 | +239.0% | 0.09% | +114.3% |
| Q1 2021 | $99,000 | -64.4% | 6,143 | +1.9% | 0.04% | -63.5% |
| Q4 2020 | $278,000 | – | 6,028 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |